Eris buying Biocon’s two non core formulations business units

Eris is acquiring Dermatology and Nephrology branded formulations business units of Biocon Biologics (BBL), a subsidiary of Biocon Limited. The transaction is a Slump Sale Revenues of the acquired businesses for FY 2022-23 was Rs. 90 Cr and Net Worth was Rs. 25 Cr as at March 31, 2023 Transaction value is Rs 366 cr, … Read more

Polyphenols: Researchers find potential treatment route for Alzheimer’s

Scientists have found that highly abundant naturally occurring plant-based polyphenols or PPs (type of compounds) — like tannic acid found in twigs of trees like Chestnut and Oak — can help create cost-effective strategy for combating Alzheimer’s disease (AD) and reduce the societal burden of this debilitating neurodegenerative disorder. The findings are part of a … Read more

We want assurance of quality of generic medicines, says IMA President

Indian Medical Association (IMA) president Dr Sharad Agarwal has raised concerns over the quality of generic medicine made in India. In an interview, he also raised concerns on restrictions placed on doctors attending medical conferences, saying educational conferences are only a discussion forum about advancements in medicine. His remarks come amid a controversy on a … Read more

Inside COVID-19 vaccine stocks: Hope vs hype (NYSE:PFE)

With the pandemic in the rearview mirror, Wall Street has mixed views on the prospects of COVID-19 vaccine makers, as the group, once the favorite among investors, is grappling with a steep decline in sales amid falling infections. The FDA-Authorized COVID-19 makers in the U.S., Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX), Moderna (NASDAQ:MRNA), and Novavax (NASDAQ:NVAX), have … Read more